MetaADEDB 2.0 @ LMMD
treprostinil
(PAJMKGZZBBTTOY-ZFORQUDYSA-N)
Structure
SMILES
CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
Type(s)
Approved; Investigational
ATC code(s)
B01AC21
Molecular Formula:
C23H34O5
Molecular Weight:
390.513
Log P:
3.5832
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
86.99
CAS Number(s):
81846-19-7
Synonym(s)
1.
treprostinil
2.
((1R,2R,3AS,9AS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3A,4,9,9A-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate
3.
Orenitram
4.
Remodulin
5.
UT-15
6.
UT-15C
7.
trepostinil sodium
8.
treprostinil diethanolamine
9.
treprostinil diolamin
10.
treprostinil diolamine
11.
treprostinil sodium
External Link(s)
MeSHC427248
PubChem Compound6918140
ChEBI50861
CHEMBLCHEMBL1237119
DrugBankDB00374
DrugCentral2720
IUPHAR/BPS Guide to PHARMACOLOGY5820
KEGGdr:D06213
Therapeutic Target DatabaseD01WUA
ZINC3800475
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 1001
Canada Vigilance: 9
15755791CTD
SIDER
Canada Vigilance
US FAERS
2NauseaFAERS: 719
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
3Drug dose omissionFAERS: 493US FAERS
4FatigueFAERS: 448
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
5DizzinessFAERS: 446
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
6PneumoniaFAERS: 442
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
7VomitingFAERS: 357
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8Pulmonary arterial hypertensionFAERS: 355
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Infusion site painFAERS: 326
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
SIDER
US FAERS
10Chest PainFAERS: 313
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
11MalaiseFAERS: 311
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
12Product use issueFAERS: 258US FAERS
13HypotensionFAERS: 245
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
14AstheniaFAERS: 242
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15FlushingFAERS: 230
Canada Vigilance: 1
15755791CTD
SIDER
Canada Vigilance
US FAERS
16PainFAERS: 205
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
17Device related infectionFAERS: 195
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
18NasopharyngitisFAERS: 186
Canada Vigilance: 2
Canada Vigilance
US FAERS
19Infusion site erythemaFAERS: 177
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
US FAERS
20Device dislocationFAERS: 166
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Fluid overloadFAERS: 161
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
22Pulmonary HypertensionFAERS: 155
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
23Disease ProgressionFAERS: 144
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Weight decreasedFAERS: 141
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Therapy cessationFAERS: 140
Canada Vigilance: 1
Canada Vigilance
US FAERS
26SyncopeFAERS: 139
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
27Chest discomfortFAERS: 126
Canada Vigilance: 1
Canada Vigilance
US FAERS
28PalpitationsFAERS: 125
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
29Back PainFAERS: 124
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30Peripheral swellingFAERS: 124
Canada Vigilance: 3
Canada Vigilance
US FAERS
31ArthralgiaFAERS: 123SIDER
US FAERS
32Respiratory FailureFAERS: 120
Canada Vigilance: 1
Canada Vigilance
US FAERS
33InfluenzaFAERS: 118
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
34Right ventricular failureFAERS: 118
Canada Vigilance: 5
Canada Vigilance
US FAERS
35Oxygen consumption increasedFAERS: 115US FAERS
36SepsisFAERS: 114
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37Infusion site infectionFAERS: 109
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
38Throat irritationFAERS: 101SIDER
US FAERS
39Feeling abnormalFAERS: 100
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
40DehydrationFAERS: 99
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41General physical health deteriorationFAERS: 96
Canada Vigilance: 5
Canada Vigilance
US FAERS
42MyalgiaFAERS: 90SIDER
US FAERS
43Abdominal PainFAERS: 89
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
44BronchitisFAERS: 85
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
45Abdominal discomfortFAERS: 77
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
46Oropharyngeal painFAERS: 77US FAERS
47Therapy non-responderFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
48Urinary tract infectionFAERS: 76SIDER
US FAERS
49Drug ineffectiveFAERS: 74
Canada Vigilance: 4
Canada Vigilance
US FAERS
50HypoxiaFAERS: 71
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
51Productive CoughFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
52ChillsFAERS: 70US FAERS
53ConstipationFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
54InfectionFAERS: 68SIDER
US FAERS
55EpistaxisFAERS: 65
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
56Incorrect dose administeredFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
57Infusion site swellingFAERS: 63
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
58AnxietyFAERS: 62SIDER
US FAERS
59SinusitisFAERS: 62
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
60Device leakageFAERS: 60
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
61AscitesFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Cardiac ArrestFAERS: 57US FAERS
63CellulitisFAERS: 57SIDER
US FAERS
64ErythemaFAERS: 57OFFSIDES
SIDER
US FAERS
65Injection site dischargeFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Infusion site dischargeFAERS: 55
Canada Vigilance: 1
Canada Vigilance
US FAERS
67PruritusFAERS: 53SIDER
US FAERS
68TremorFAERS: 52US FAERS
69Atrial FibrillationFAERS: 51US FAERS
70Device malfunctionFAERS: 51
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
71DyspepsiaFAERS: 50SIDER
US FAERS
72Accidental overdoseFAERS: 49
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
73Respiratory distressFAERS: 47US FAERS
74Cerebrovascular accidentFAERS: 45US FAERS
75Myocardial InfarctionFAERS: 45US FAERS
76SomnolenceFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
77Injection site painFAERS: 43US FAERS
78Clostridium difficile infectionFAERS: 42US FAERS
79Device breakageFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Musculoskeletal PainFAERS: 42US FAERS
81OverdoseFAERS: 41US FAERS
82TachycardiaFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
83LethargyFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Pericardial effusionFAERS: 37
Canada Vigilance: 3
Canada Vigilance
US FAERS
85Joint swellingFAERS: 36US FAERS
86Neck PainFAERS: 36SIDER
US FAERS
87Complication associated with deviceFAERS: 35US FAERS
88Infusion site indurationFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Injection site erythemaFAERS: 35OFFSIDES
US FAERS
90Device occlusionFAERS: 32US FAERS
91Infusion site pruritusFAERS: 32OFFSIDES
US FAERS
92Infusion site warmthFAERS: 32US FAERS
93ThrombosisFAERS: 32US FAERS
94Blood potassium decreasedFAERS: 31US FAERS
95PresyncopeFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
96AsthmaFAERS: 29US FAERS
97Pulmonary EmbolismFAERS: 28SIDER
US FAERS
98Device related sepsisFAERS: 27US FAERS
99WheezingFAERS: 27SIDER
US FAERS
100Burning sensationFAERS: 26
Canada Vigilance: 4
Canada Vigilance
US FAERS
101Injection site infectionFAERS: 26OFFSIDES
US FAERS
102Mental status changesFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Pulmonary arterial pressure increasedFAERS: 26US FAERS
104SwellingFAERS: 26US FAERS
105Infusion site reactionFAERS: 24
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
106Medical device complicationFAERS: 24US FAERS
107Accidental exposure to productFAERS: 23US FAERS
108Acute respiratory failureFAERS: 23US FAERS
109DysgeusiaFAERS: 23US FAERS
110FlatulenceFAERS: 23US FAERS
111Infusion site abscessFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Infusion site cellulitisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Product dose omissionFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
114Acute kidney injuryFAERS: 22US FAERS
115Adverse eventFAERS: 22US FAERS
116AlopeciaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Infusion site irritationFAERS: 22
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
118ThrombocytopeniaFAERS: 22SIDER
US FAERS
119Thrombosis in deviceFAERS: 22US FAERS
120DysphoniaFAERS: 21US FAERS
121HerniaFAERS: 21US FAERS
122HypersensitivityFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Inappropriate schedule of drug administrationFAERS: 21US FAERS
124VertigoFAERS: 21US FAERS
125Visual ImpairmentFAERS: 21US FAERS
126Blood glucose increasedFAERS: 20US FAERS
127Bone painFAERS: 20SIDER
US FAERS
128Device infusion issueFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Device use errorFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Device use issueFAERS: 20US FAERS
131Injection site pruritusFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
132CyanosisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
133GoutFAERS: 18SIDER
US FAERS
134Incorrect dose administered by deviceFAERS: 18US FAERS
135Infusion site noduleFAERS: 18US FAERS
136SclerodermaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Drug administration errorFAERS: 17OFFSIDES
US FAERS
138Feeling ColdFAERS: 17US FAERS
139PallorFAERS: 17SIDER
US FAERS
140Post procedural complicationFAERS: 17US FAERS
141RestlessnessFAERS: 17US FAERS
142Secretion dischargeFAERS: 17US FAERS
143StressFAERS: 17US FAERS
144UrticariaFAERS: 17US FAERS
145Drug titration errorFAERS: 16US FAERS
146Infusion Site ExtravasationFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Night sweatsFAERS: 16US FAERS
148Respiratory tract congestionFAERS: 16US FAERS
149CholelithiasisFAERS: 15US FAERS
150Infusion site rashFAERS: 15OFFSIDES
US FAERS
151NeuralgiaFAERS: 15US FAERS
152PregnancyFAERS: 15US FAERS
153Wrong technique in product usage processFAERS: 15US FAERS
154Head discomfortFAERS: 14US FAERS
155Infusion site pustuleFAERS: 14US FAERS
156Musculoskeletal stiffnessFAERS: 14US FAERS
157NervousnessFAERS: 14SIDER
US FAERS
158RetchingFAERS: 14US FAERS
159Septic ShockFAERS: 14US FAERS
160SneezingFAERS: 14US FAERS
161TinnitusFAERS: 14US FAERS
162Infusion site inflammationFAERS: 13US FAERS
163Oxygen saturation abnormalFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
164RalesFAERS: 13US FAERS
165Unresponsive to stimuliFAERS: 13US FAERS
166ArthritisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Device battery issueFAERS: 12US FAERS
168Dry skinFAERS: 12US FAERS
169Injection site extravasationFAERS: 12US FAERS
170Intestinal ObstructionFAERS: 12US FAERS
171Joint injuryFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Maternal exposure during pregnancyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
173PancreatitisFAERS: 12US FAERS
174Pulmonary FibrosisFAERS: 12US FAERS
175ShockFAERS: 12SIDER
US FAERS
176TransplantFAERS: 12US FAERS
177Vascular device infectionFAERS: 12
Canada Vigilance: 6
Canada Vigilance
US FAERS
178AgitationFAERS: 11US FAERS
179Blood count abnormalFAERS: 11US FAERS
180Blood pressure fluctuationFAERS: 11US FAERS
181Blood sodium decreasedFAERS: 11US FAERS
182Lower respiratory tract infectionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
183Medication ErrorFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
184Musculoskeletal discomfortFAERS: 11SIDER
US FAERS
185PneumothoraxFAERS: 11US FAERS
186Restless Legs SyndromeFAERS: 11US FAERS
187Unevaluable eventFAERS: 11US FAERS
188Walking distance test abnormalFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
189Depressed moodFAERS: 10US FAERS
190DiverticulitisFAERS: 10US FAERS
191Limb discomfortFAERS: 10US FAERS
192Muscle tightnessFAERS: 10US FAERS
193Oral painFAERS: 10US FAERS
194Respiratory arrestFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Respiratory tract infection viralFAERS: 10US FAERS
196Rhinovirus infectionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
197Skin irritationFAERS: 10US FAERS
198UlcerFAERS: 10US FAERS
199Atrial FlutterFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
200Blood creatinine increasedFAERS: 9US FAERS
201Blood potassium increasedFAERS: 9US FAERS
202CardiomegalyFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
203Catheter placementFAERS: 9US FAERS
204CystitisFAERS: 9US FAERS
205Device alarm issueFAERS: 9US FAERS
206Ear discomfortFAERS: 9US FAERS
207Eye irritationFAERS: 9US FAERS
208Eye painFAERS: 9US FAERS
209Feeling jitteryFAERS: 9US FAERS
210Gastrointestinal infectionFAERS: 9US FAERS
211HypersomniaFAERS: 9US FAERS
212Infusion site discomfortFAERS: 9US FAERS
213LacerationFAERS: 9US FAERS
214Memory impairmentFAERS: 9US FAERS
215Musculoskeletal chest painFAERS: 9US FAERS
216Product use in unapproved indicationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Rheumatoid ArthritisFAERS: 9US FAERS
218Sudden Cardiac DeathFAERS: 9US FAERS
219Supraventricular tachycardiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
220Tooth ExtractionFAERS: 9US FAERS
221AbscessFAERS: 8OFFSIDES
US FAERS
222Activities of daily living impairedFAERS: 8US FAERS
223AgeusiaFAERS: 8US FAERS
224AmnesiaFAERS: 8US FAERS
225Carbon dioxide increasedFAERS: 8US FAERS
226CataractFAERS: 8US FAERS
227ColitisFAERS: 8US FAERS
228GastroenteritisFAERS: 8US FAERS
229Injection site irritationFAERS: 8US FAERS
230Loss of personal independence in daily activitiesFAERS: 8US FAERS
231Muscle strainFAERS: 8US FAERS
232PolyuriaFAERS: 8US FAERS
233Product physical issueFAERS: 8US FAERS
234Pulmonary congestionFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
235ToothacheFAERS: 8US FAERS
236Blood glucose decreasedFAERS: 7US FAERS
237Catheter site infectionFAERS: 7OFFSIDES
US FAERS
238Deep Vein ThrombosisFAERS: 7US FAERS
239Device damageFAERS: 7US FAERS
240Device related thrombosisFAERS: 7US FAERS
241EructationFAERS: 7US FAERS
242Inappropriate schedule of product administrationFAERS: 7US FAERS
243Low birth weight babyFAERS: 7US FAERS
244Mechanical ventilationFAERS: 7US FAERS
245Product leakageFAERS: 7US FAERS
246Sudden deathFAERS: 7US FAERS
247Blood magnesium decreasedFAERS: 6US FAERS
248CholecystitisFAERS: 6US FAERS
249Clostridium difficile colitisFAERS: 6US FAERS
250Cold sweatFAERS: 6US FAERS
251DeliriumFAERS: 6US FAERS
252Device connection issueFAERS: 6US FAERS
253DisorientationFAERS: 6US FAERS
254Electrolyte imbalanceFAERS: 6US FAERS
255Facial PainFAERS: 6US FAERS
256Failure to ThriveFAERS: 6US FAERS
257Hepatic EncephalopathyFAERS: 6US FAERS
258Incorrect drug administration rateFAERS: 6US FAERS
259InflammationFAERS: 6US FAERS
260Infusion site bruisingFAERS: 6OFFSIDES
US FAERS
261Infusion site injuryFAERS: 6US FAERS
262Infusion site vesiclesFAERS: 6US FAERS
263Injection site pustuleFAERS: 6US FAERS
264Injection site vesiclesFAERS: 6US FAERS
265No adverse eventFAERS: 6US FAERS
266Product quality issueFAERS: 6US FAERS
267PsoriasisFAERS: 6US FAERS
268Pulmonary painFAERS: 6US FAERS
269Sinus headacheFAERS: 6US FAERS
270SluggishnessFAERS: 6US FAERS
271StomatitisFAERS: 6US FAERS
272Upper-airway cough syndromeFAERS: 6US FAERS
273AbasiaFAERS: 5US FAERS
274Ammonia increasedFAERS: 5US FAERS
275AphoniaFAERS: 5US FAERS
276ArthropathyFAERS: 5US FAERS
277BedriddenFAERS: 5US FAERS
278BradycardiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
279ChokingFAERS: 5US FAERS
280DementiaFAERS: 5US FAERS
281Device FailureFAERS: 5OFFSIDES
US FAERS
282Diabetes MellitusFAERS: 5US FAERS
283Dialysis related complicationFAERS: 5US FAERS
284DiscomfortFAERS: 5SIDER
US FAERS
285Disease complicationFAERS: 5US FAERS
286Ear congestionFAERS: 5US FAERS
287Echocardiogram abnormalFAERS: 5US FAERS
288EczemaFAERS: 5US FAERS
289Emotional distressFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
290Feeling of body temperature changeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
291Food AllergyFAERS: 5US FAERS
292GastritisFAERS: 5US FAERS
293LaryngitisFAERS: 5US FAERS
294Limb injuryFAERS: 5US FAERS
295LymphomaFAERS: 5US FAERS
296Poor quality sleepFAERS: 5US FAERS
297SarcoidosisFAERS: 5US FAERS
298Systemic SclerodermaFAERS: 5US FAERS
299Thermal burnFAERS: 5US FAERS
300Tooth InfectionFAERS: 5US FAERS
301Toxicity to various agentsFAERS: 5US FAERS
302Transplantation complicationFAERS: 5US FAERS
303White blood cell count decreasedFAERS: 5US FAERS
304Wound InfectionFAERS: 5US FAERS
305Abdominal InfectionFAERS: 4US FAERS
306Acute myocardial infarctionFAERS: 4US FAERS
307Altered state of consciousnessFAERS: 4US FAERS
308AneurysmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Ankle FractureFAERS: 4US FAERS
310Blood iron decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Brain natriuretic peptide increasedFAERS: 4US FAERS
312BronchospasmFAERS: 4US FAERS
313Cardiac FlutterFAERS: 4US FAERS
314Catheter site dischargeFAERS: 4OFFSIDES
US FAERS
315Catheter site painFAERS: 4OFFSIDES
US FAERS
316Chronic respiratory failureFAERS: 4US FAERS
317DeafnessFAERS: 4US FAERS
318Device difficult to useFAERS: 4US FAERS
319Drug abuseFAERS: 4US FAERS
320Flank PainFAERS: 4US FAERS
321Gait inabilityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
322HypophagiaFAERS: 4US FAERS
323HysterectomyFAERS: 4US FAERS
324Injection site warmthFAERS: 4US FAERS
325Malabsorption from injection siteFAERS: 4US FAERS
326MalnutritionFAERS: 4US FAERS
327NeutropeniaFAERS: 4US FAERS
328Ocular discomfortFAERS: 4US FAERS
329Oral candidiasisFAERS: 4US FAERS
330Oxygen consumption decreasedFAERS: 4US FAERS
331Pain of skinFAERS: 4US FAERS
332Pancreatic carcinomaFAERS: 4US FAERS
333ParacentesisFAERS: 4US FAERS
334PleurisyFAERS: 4OFFSIDES
US FAERS
335Poor peripheral circulationFAERS: 4US FAERS
336Procedural complicationFAERS: 4US FAERS
337Product preparation errorFAERS: 4US FAERS
338Product taste abnormalFAERS: 4US FAERS
339Pulmonary arterial pressure abnormalFAERS: 4US FAERS
340Pulmonary hypertensive crisisFAERS: 4OFFSIDES
US FAERS
341PyelonephritisFAERS: 4US FAERS
342Quality of life decreasedFAERS: 4US FAERS
343Rash erythematousFAERS: 4US FAERS
344Skin reactionFAERS: 4US FAERS
345Terminal stateFAERS: 4US FAERS
346TrismusFAERS: 4US FAERS
347Urinary RetentionFAERS: 4US FAERS
348Venoocclusive diseaseFAERS: 4US FAERS
349Viral upper respiratory tract infectionFAERS: 4US FAERS
350Wrong technique in drug usage processFAERS: 4US FAERS
351AcidosisFAERS: 3US FAERS
352Arthropod biteFAERS: 3US FAERS
353Blood potassium abnormalFAERS: 3US FAERS
354Blood urea increasedFAERS: 3US FAERS
355Blood urine presentFAERS: 3US FAERS
356Bowel movement irregularityFAERS: 3US FAERS
357Brain AbscessFAERS: 3US FAERS
358Brain DeathFAERS: 3US FAERS
359Cardiac TamponadeFAERS: 3OFFSIDES
US FAERS
360Cardiac ablationFAERS: 3US FAERS
361Cataract operationFAERS: 3US FAERS
362Catheter related infectionFAERS: 3OFFSIDES
US FAERS
363Central line infectionFAERS: 3OFFSIDES
US FAERS
364Cor pulmonaleFAERS: 3US FAERS
365DermatitisFAERS: 3SIDER
US FAERS
366Diabetic KetoacidosisFAERS: 3US FAERS
367Drug dispensing errorFAERS: 3US FAERS
368DysarthriaFAERS: 3US FAERS
369DysuriaFAERS: 3US FAERS
370Exposure via direct contactFAERS: 3US FAERS
371Eye InfectionFAERS: 3US FAERS
372FibromyalgiaFAERS: 3US FAERS
373Frustration tolerance decreasedFAERS: 3US FAERS
374Full blood count decreasedFAERS: 3US FAERS
375Gastrointestinal PainFAERS: 3SIDER
US FAERS
376GlaucomaFAERS: 3US FAERS
377GlossitisFAERS: 3US FAERS
378Grip strength decreasedFAERS: 3US FAERS
379HepatomegalyFAERS: 3US FAERS
380Hepatorenal SyndromeFAERS: 3US FAERS
381Implant site extravasationFAERS: 3US FAERS
382IncontinenceFAERS: 3US FAERS
383Infusion site hypersensitivityFAERS: 3US FAERS
384Infusion site massFAERS: 3US FAERS
385Injection Site ReactionFAERS: 3US FAERS
386Injection site discomfortFAERS: 3US FAERS
387Injection site scabFAERS: 3US FAERS
388Intentional product misuseFAERS: 3US FAERS
389Intentional product use issueFAERS: 3US FAERS
390Irritable Bowel SyndromeFAERS: 3US FAERS
391Joint stiffnessFAERS: 3US FAERS
392Lip swellingFAERS: 3US FAERS
393LymphadenopathyFAERS: 3US FAERS
394MenorrhagiaFAERS: 3US FAERS
395Mood swingsFAERS: 3US FAERS
396Myocardial necrosis marker increasedFAERS: 3US FAERS
397OliguriaFAERS: 3US FAERS
398OnychoclasisFAERS: 3US FAERS
399Oxygen saturation increasedFAERS: 3US FAERS
400Paranasal sinus hypersecretionFAERS: 3US FAERS
401Pharmaceutical product complaintFAERS: 3US FAERS
402Post procedural infectionFAERS: 3US FAERS
403Pulmonary thrombosisFAERS: 3US FAERS
404Respiratory tract inflammationFAERS: 3US FAERS
405Right Ventricular DysfunctionFAERS: 3US FAERS
406RosaceaFAERS: 3US FAERS
407SciaticaFAERS: 3US FAERS
408Sjogren's SyndromeFAERS: 3US FAERS
409Skin UlcerFAERS: 3US FAERS
410Soft tissue swellingFAERS: 3US FAERS
411Suture related complicationFAERS: 3US FAERS
412ThirstFAERS: 3US FAERS
413TracheitisFAERS: 3US FAERS
414Tracheostomy malfunctionFAERS: 3US FAERS
415Urinary IncontinenceFAERS: 3US FAERS
416Vascular Access ComplicationFAERS: 3US FAERS
417Wrong technique in device usage processFAERS: 3US FAERS
418Accidental exposure to product by childFAERS: 2US FAERS
419Accidental underdoseFAERS: 2US FAERS
420AcneFAERS: 2OFFSIDES
US FAERS
421AngioedemaFAERS: 2SIDER
US FAERS
422Animal biteFAERS: 2US FAERS
423AppendicitisFAERS: 2US FAERS
424Arterial thrombosisFAERS: 2US FAERS
425ArteriosclerosisFAERS: 2US FAERS
426AtelectasisFAERS: 2US FAERS
427Back disorderFAERS: 2US FAERS
428Bilevel positive airway pressureFAERS: 2US FAERS
429Blister ruptureFAERS: 2US FAERS
430Blood calcium abnormalFAERS: 2US FAERS
431Blood glucose abnormalFAERS: 2US FAERS
432Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
433Bronchopulmonary DysplasiaFAERS: 2US FAERS
434CalcinosisFAERS: 2US FAERS
435Cardiac valve vegetationFAERS: 2US FAERS
436Choking sensationFAERS: 2US FAERS
437Cholecystitis infectiveFAERS: 2US FAERS
438Claudication of jaw musclesFAERS: 2US FAERS
439ColectomyFAERS: 2US FAERS
440Compression fractureFAERS: 2US FAERS
441Croup infectiousFAERS: 2US FAERS
442CryingFAERS: 2US FAERS
443Culture urine positiveFAERS: 2US FAERS
444Dental cariesFAERS: 2US FAERS
445DependenceFAERS: 2US FAERS
446Device extrusionFAERS: 2US FAERS
447Device kinkFAERS: 2US FAERS
448Diabetes mellitus inadequate controlFAERS: 2US FAERS
449Drug exposure during pregnancyFAERS: 2US FAERS
450DysenteryFAERS: 2US FAERS
451Electrocardiogram abnormalFAERS: 2US FAERS
452Emotional disorderFAERS: 2US FAERS
453EmpyemaFAERS: 2US FAERS
454EndarterectomyFAERS: 2US FAERS
455EndocarditisFAERS: 2OFFSIDES
US FAERS
456Enterobacter sepsisFAERS: 2OFFSIDES
US FAERS
457Enterococcal infectionFAERS: 2OFFSIDES
US FAERS
458Escherichia infectionFAERS: 2US FAERS
459Euphoric moodFAERS: 2US FAERS
460Expired product administeredFAERS: 2US FAERS
461Extra dose administeredFAERS: 2US FAERS
462Fluid imbalanceFAERS: 2US FAERS
463Food PoisoningFAERS: 2US FAERS
464Gastric ulcerFAERS: 2US FAERS
465Graft infectionFAERS: 2US FAERS
466GranulomaFAERS: 2US FAERS
467Hernia painFAERS: 2US FAERS
468HydrothoraxFAERS: 2US FAERS
469HyperacusisFAERS: 2US FAERS
470HyperchlorhydriaFAERS: 2US FAERS
471HyperventilationFAERS: 2US FAERS
472Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
473Impaired gastric emptyingFAERS: 2US FAERS
474Impaired quality of lifeFAERS: 2US FAERS
475Implant site infectionFAERS: 2US FAERS
476Incorrect route of drug administrationFAERS: 2US FAERS
477Increased upper airway secretionFAERS: 2US FAERS
478Infected cystFAERS: 2US FAERS
479Infusion site drynessFAERS: 2US FAERS
480Infusion site erosionFAERS: 2US FAERS
481Infusion site scabFAERS: 2US FAERS
482Infusion site scarFAERS: 2US FAERS
483Infusion site streakingFAERS: 2US FAERS
484Infusion site thrombosisFAERS: 2US FAERS
485Injection site abscessFAERS: 2US FAERS
486Injection site bruisingFAERS: 2US FAERS
487Intestinal PerforationFAERS: 2US FAERS
488Intracranial AneurysmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
489Intracranial massFAERS: 2US FAERS
490IntussusceptionFAERS: 2US FAERS
491Living in residential institutionFAERS: 2US FAERS
492Loose toothFAERS: 2US FAERS
493Malabsorption from administration siteFAERS: 2US FAERS
494Malignant Atrophic PapulosisFAERS: 2US FAERS
495Medical device removalFAERS: 2US FAERS
496Medical procedureFAERS: 2US FAERS
497MeningitisFAERS: 2US FAERS
498Mental impairmentFAERS: 2US FAERS
499Morganella infectionFAERS: 2US FAERS
500NephrolithiasisFAERS: 2US FAERS
501Oral viral infectionFAERS: 2US FAERS
502OsteomyelitisFAERS: 2US FAERS
503OsteoporosisFAERS: 2US FAERS
504Paranasal sinus discomfortFAERS: 2US FAERS
505ParanoiaFAERS: 2US FAERS
506Perforated ulcerFAERS: 2US FAERS
507PericarditisFAERS: 2US FAERS
508PetechiaeFAERS: 2US FAERS
509Physical assaultFAERS: 2SIDER
US FAERS
510PneumonitisFAERS: 2US FAERS
511Portal HypertensionFAERS: 2OFFSIDES
US FAERS
512Product label confusionFAERS: 2US FAERS
513Pulmonary arterial pressure decreasedFAERS: 2US FAERS
514Rectal ProlapseFAERS: 2US FAERS
515Renal massFAERS: 2US FAERS
516Respiratory tract irritationFAERS: 2US FAERS
517Restrictive pulmonary diseaseFAERS: 2US FAERS
518RhinalgiaFAERS: 2US FAERS
519RhonchiFAERS: 2US FAERS
520Rubber sensitivityFAERS: 2US FAERS
521ScabFAERS: 2US FAERS
522Septic embolusFAERS: 2OFFSIDES
US FAERS
523Sinus painFAERS: 2US FAERS
524Skin lesionFAERS: 2US FAERS
525SplenomegalyFAERS: 2US FAERS
526Squamous cell carcinomaFAERS: 2US FAERS
527Status EpilepticusFAERS: 2US FAERS
528StenosisFAERS: 2US FAERS
529Subcutaneous drug absorption impairedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
530Suture ruptureFAERS: 2US FAERS
531Tension HeadacheFAERS: 2US FAERS
532Therapy changeFAERS: 2US FAERS
533Thoracic vertebral fractureFAERS: 2US FAERS
534ThyroiditisFAERS: 2OFFSIDES
US FAERS
535TonsillectomyFAERS: 2US FAERS
536Troponin increasedFAERS: 2US FAERS
537Vascular device occlusionFAERS: 2US FAERS
538Withdrawal of life supportFAERS: 2US FAERS
539jaundiceFAERS: 2US FAERS
540nervous system disorderFAERS: 2US FAERS
541skin abrasionFAERS: 2US FAERS
542Abdominal AbscessFAERS: 1US FAERS
543Abdominal cavity drainageFAERS: 1US FAERS
544AcarodermatitisFAERS: 1US FAERS
545Accelerated Idioventricular RhythmFAERS: 1US FAERS
546Accidental exposureFAERS: 1US FAERS
547Acute Chest SyndromeFAERS: 1US FAERS
548Acute right ventricular failureFAERS: 1US FAERS
549African TrypanosomiasisFAERS: 1US FAERS
550AkathisiaFAERS: 1US FAERS
551Alanine Aminotransferase IncreasedFAERS: 1US FAERS
552Alcohol abuseFAERS: 1US FAERS
553Alcohol poisoningFAERS: 1US FAERS
554Allergic sinusitisFAERS: 1US FAERS
555Alveolar capillary dysplasiaFAERS: 1US FAERS
556Ammonia abnormalFAERS: 1US FAERS
557AngerFAERS: 1US FAERS
558Angina PectorisFAERS: 1US FAERS
559AngioplastyFAERS: 1US FAERS
560Antibiotic therapyFAERS: 1US FAERS
561Antinuclear antibody increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
562AnuriaFAERS: 1US FAERS
563Aortic AneurysmFAERS: 1US FAERS
564Aortic RuptureFAERS: 1US FAERS
565Aortic anastomosisFAERS: 1US FAERS
566Aortic aneurysm repairFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
567ApathyFAERS: 1US FAERS
568Apparent deathFAERS: 1US FAERS
569Application site dischargeFAERS: 1US FAERS
570Application site erythemaFAERS: 1US FAERS
571Arteriovenous fistula thrombosisFAERS: 1US FAERS
572Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
573AsphyxiaFAERS: 1US FAERS
574AsthenopiaFAERS: 1US FAERS
575AstigmatismFAERS: 1US FAERS
576Atrioventricular BlockFAERS: 1US FAERS
577Atypical pneumoniaFAERS: 1US FAERS
578Autoimmune hepatitisFAERS: 1US FAERS
579Autoimmune pancytopeniaFAERS: 1US FAERS
580Bacterial sepsisFAERS: 1OFFSIDES
US FAERS
581Bacterial test positiveFAERS: 1US FAERS
582Bacterial tracheitisFAERS: 1US FAERS
583Bed restFAERS: 1US FAERS
584BendopnoeaFAERS: 1US FAERS
585Bile Duct StenosisFAERS: 1US FAERS
586Biliary ColicFAERS: 1US FAERS
587Bipolar DisorderFAERS: 1US FAERS
588BlindnessFAERS: 1US FAERS
589Blood PressureFAERS: 1US FAERS
590Blood creatine increasedFAERS: 1US FAERS
591Blood creatinine abnormalFAERS: 1US FAERS
592Blood electrolytes decreasedFAERS: 1US FAERS
593Blood gases abnormalFAERS: 1US FAERS
594Blood immunoglobulin G decreasedFAERS: 1US FAERS
595Blood pH increasedFAERS: 1US FAERS
596Blood pressure difference of extremitiesFAERS: 1US FAERS
597Blood pressure orthostatic abnormalFAERS: 1US FAERS
598Blood sodium abnormalFAERS: 1US FAERS
599Blood sodiumFAERS: 1US FAERS
600Bone contusionFAERS: 1US FAERS
601Brain natriuretic peptide decreasedFAERS: 1US FAERS
602Breast tendernessFAERS: 1US FAERS
603Breath HoldingFAERS: 1US FAERS
604Bronchial HyperreactivityFAERS: 1US FAERS
605BronchiectasisFAERS: 1US FAERS
606BronchiolitisFAERS: 1US FAERS
607BronchoscopyFAERS: 1US FAERS
608BursitisFAERS: 1US FAERS
609CREST SyndromeFAERS: 1US FAERS
610Capillary nail refill testFAERS: 1US FAERS
611Carbon Monoxide PoisoningFAERS: 1US FAERS
612Cardiac DeathFAERS: 1US FAERS
613Cardiac discomfortFAERS: 1US FAERS
614Cardiac dysfunctionFAERS: 1US FAERS
615Cardiac procedure complicationFAERS: 1US FAERS
616Cardiovascular evaluationFAERS: 1US FAERS
617CarditisFAERS: 1US FAERS
618Carotid artery occlusionFAERS: 1US FAERS
619CatatoniaFAERS: 1US FAERS
620Catheter bacteraemiaFAERS: 1OFFSIDES
US FAERS
621Catheter culture positiveFAERS: 1US FAERS
622Catheter managementFAERS: 1US FAERS
623Catheter related complicationFAERS: 1OFFSIDES
US FAERS
624Catheter site extravasationFAERS: 1US FAERS
625Catheter site inflammationFAERS: 1US FAERS
626Catheter site noduleFAERS: 1US FAERS
627Catheter site scabFAERS: 1US FAERS
628Central venous catheter removalFAERS: 1US FAERS
629Cervix carcinoma recurrentFAERS: 1US FAERS
630ChemotherapyFAERS: 1US FAERS
631Chronic gastritisFAERS: 1US FAERS
632Chronic right ventricular failureFAERS: 1US FAERS
633Clostridium difficile sepsisFAERS: 1US FAERS
634Combined pulmonary fibrosis and emphysemaFAERS: 1US FAERS
635Complication of device insertionFAERS: 1US FAERS
636Congenital diaphragmatic herniaFAERS: 1US FAERS
637Congenital renal disorderFAERS: 1US FAERS
638ConjunctivitisFAERS: 1US FAERS
639Consciousness fluctuatingFAERS: 1US FAERS
640Coronary Artery DiseaseFAERS: 1US FAERS
641Critical IllnessFAERS: 1US FAERS
642Cyst removalFAERS: 1US FAERS
643Cystic FibrosisFAERS: 1US FAERS
644CystFAERS: 1US FAERS
645Dependence on oxygen therapyFAERS: 1US FAERS
646Depressed Level of ConsciousnessFAERS: 1US FAERS
647Depression suicidalFAERS: 1US FAERS
648Device adhesion issueFAERS: 1US FAERS
649Device allergyFAERS: 1US FAERS
650Device computer issueFAERS: 1US FAERS
651Device defectiveFAERS: 1US FAERS
652Device looseningFAERS: 1US FAERS
653Device power source issueFAERS: 1US FAERS
654Diaphragmatic HerniaFAERS: 1US FAERS
655DiplopiaFAERS: 1US FAERS
656Diuretic therapyFAERS: 1US FAERS
657Diverticular perforationFAERS: 1US FAERS
658DroolingFAERS: 1US FAERS
659Drug ToleranceFAERS: 1US FAERS
660Drug administered in wrong deviceFAERS: 1US FAERS
661Drug ineffective for unapproved indicationFAERS: 1US FAERS
662Drug resistanceFAERS: 1US FAERS
663DuodenitisFAERS: 1US FAERS
664DysphemiaFAERS: 1US FAERS
665Ear tube insertionFAERS: 1US FAERS
666Ejection Fraction DecreasedFAERS: 1US FAERS
667ElectroencephalogramFAERS: 1US FAERS
668Embedded deviceFAERS: 1US FAERS
669EmbolismFAERS: 1US FAERS
670Enamel anomalyFAERS: 1US FAERS
671EncephalitisFAERS: 1US FAERS
672Endometrial hypertrophyFAERS: 1US FAERS
673Enterococcal sepsisFAERS: 1US FAERS
674EpiglottitisFAERS: 1US FAERS
675Escherichia sepsisFAERS: 1US FAERS
676Escherichia urinary tract infectionFAERS: 1US FAERS
677Excessive eye blinkingFAERS: 1US FAERS
678Expired device usedFAERS: 1US FAERS
679Exposure via breast milkFAERS: 1US FAERS
680Exposure via eye contactFAERS: 1US FAERS
681Facial ParesisFAERS: 1US FAERS
682Facial paralysisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
683FibrosisFAERS: 1US FAERS
684Flat affectFAERS: 1US FAERS
685FractureFAERS: 1US FAERS
686FrustrationFAERS: 1US FAERS
687Fungal pharyngitisFAERS: 1US FAERS
688GangreneFAERS: 1US FAERS
689Gastric infectionFAERS: 1OFFSIDES
US FAERS
690Gastrointestinal hypermotilityFAERS: 1US FAERS
691Gastrointestinal inflammationFAERS: 1US FAERS
692Gastrointestinal sounds abnormalFAERS: 1US FAERS
693Gastrointestinal ulcerFAERS: 1US FAERS
694Gastrointestinal viral infectionFAERS: 1US FAERS
695Gastrointestinal wall thickeningFAERS: 1US FAERS
696Gastrostomy tube site complicationFAERS: 1US FAERS
697General physical condition abnormalFAERS: 1US FAERS
698Gestational DiabetesFAERS: 1US FAERS
699Gingival erythemaFAERS: 1US FAERS
700GingivitisFAERS: 1US FAERS
701GlioblastomaFAERS: 1US FAERS
702Gluten sensitivityFAERS: 1US FAERS
703Growth failureFAERS: 1US FAERS
704HemiparesisFAERS: 1OFFSIDES
US FAERS
705Hepatic cancer metastaticFAERS: 1US FAERS
706Hepatic cancer stage IVFAERS: 1US FAERS
707Hepatic congestionFAERS: 1US FAERS
708Hepatopulmonary SyndromeFAERS: 1US FAERS
709Hip surgeryFAERS: 1US FAERS
710HordeolumFAERS: 1US FAERS
711Hospice CareFAERS: 1US FAERS
712House dust allergyFAERS: 1US FAERS
713HungerFAERS: 1US FAERS
714HydrocephalusFAERS: 1US FAERS
715HyperkeratosisFAERS: 1US FAERS
716Hyperosmolar stateFAERS: 1US FAERS
717HypogeusiaFAERS: 1US FAERS
718HypokinesiaFAERS: 1US FAERS
719HypometabolismFAERS: 1US FAERS
720HypothyroidismFAERS: 1US FAERS
721Immune thrombocytopenic purpuraFAERS: 1US FAERS
722Immunoglobulin TherapyFAERS: 1US FAERS
723Impaired self-careFAERS: 1US FAERS
724ImpetigoFAERS: 1US FAERS
725Inability to afford medicationFAERS: 1US FAERS
726Incision site painFAERS: 1US FAERS
727IncoherentFAERS: 1US FAERS
728Incorrect product storageFAERS: 1US FAERS
729Incorrect route of product administrationFAERS: 1US FAERS
730Increased bronchial secretionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
731Increased tendency to bruiseFAERS: 1US FAERS
732Infectious MononucleosisFAERS: 1US FAERS
733Infectious colitisFAERS: 1US FAERS
734Influenza A virus test positiveFAERS: 1US FAERS
735Infusion site coldnessFAERS: 1US FAERS
736Infusion site cystFAERS: 1US FAERS
737Infusion site exfoliationFAERS: 1US FAERS
738Infusion site maculeFAERS: 1US FAERS
739Infusion site necrosisFAERS: 1US FAERS
740Infusion site urticariaFAERS: 1US FAERS
741Initial insomniaFAERS: 1US FAERS
742Injection site cellulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
743Injection site inflammationFAERS: 1US FAERS
744Injection site injuryFAERS: 1US FAERS
745Injection site noduleFAERS: 1US FAERS
746Injection site papuleFAERS: 1US FAERS
747Injection site phlebitisFAERS: 1US FAERS
748Injection site urticariaFAERS: 1US FAERS
749Intentional dose omissionFAERS: 1US FAERS
750Intentional drug misuseFAERS: 1US FAERS
751Intermittent ClaudicationFAERS: 1US FAERS
752Intracardiac pressure increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
753Iron deficiencyFAERS: 1US FAERS
754KetoacidosisFAERS: 1US FAERS
755Kidney ablationFAERS: 1US FAERS
756Klebsiella test positiveFAERS: 1US FAERS
757Left Ventricular HypertrophyFAERS: 1US FAERS
758Life expectancy shortenedFAERS: 1US FAERS
759Limb operationFAERS: 1US FAERS
760Lip erythemaFAERS: 1US FAERS
761Livedo ReticularisFAERS: 1US FAERS
762Lobar PneumoniaFAERS: 1US FAERS
763Local reactionFAERS: 1US FAERS
764Lower respiratory tract infection fungalFAERS: 1US FAERS
765Lung AbscessFAERS: 1US FAERS
766Lung hyperinflationFAERS: 1US FAERS
767Lung transplant rejectionFAERS: 1US FAERS
768Lupus-like syndromeFAERS: 1US FAERS
769Lymph nodes scan abnormalFAERS: 1US FAERS
770LymphadenitisFAERS: 1US FAERS
771MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
772Macular degenerationFAERS: 1US FAERS
773Malabsorption from application siteFAERS: 1US FAERS
774MalabsorptionFAERS: 1US FAERS
775Malignant ascitesFAERS: 1US FAERS
776Mediastinal massFAERS: 1US FAERS
777Medical device changeFAERS: 1US FAERS
778Medical device site infectionFAERS: 1US FAERS
779Medical device site swellingFAERS: 1US FAERS
780Medical induction of comaFAERS: 1US FAERS
781Medication residue presentFAERS: 1US FAERS
782MenopauseFAERS: 1US FAERS
783MesotheliomaFAERS: 1US FAERS
784Metabolic function test abnormalFAERS: 1US FAERS
785MetrorrhagiaFAERS: 1US FAERS
786Micturition frequency decreasedFAERS: 1US FAERS
787Middle insomniaFAERS: 1US FAERS
788Migraine with AuraFAERS: 1US FAERS
789MiliariaFAERS: 1US FAERS
790Mixed Connective Tissue DiseaseFAERS: 1US FAERS
791MoaningFAERS: 1US FAERS
792Motion SicknessFAERS: 1US FAERS
793Muscle RigidityFAERS: 1US FAERS
794Mycotic allergyFAERS: 1US FAERS
795N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
796Nasal discomfortFAERS: 1US FAERS
797Nasal pruritusFAERS: 1US FAERS
798Needle issueFAERS: 1US FAERS
799Nipple painFAERS: 1US FAERS
800NoduleFAERS: 1US FAERS
801Noninfective encephalitisFAERS: 1US FAERS
802Nonspecific reactionFAERS: 1US FAERS
803ObesityFAERS: 1US FAERS
804Occult blood positiveFAERS: 1US FAERS
805OnychomycosisFAERS: 1US FAERS
806Oral mucosal erythemaFAERS: 1US FAERS
807Oral mucosal exfoliationFAERS: 1US FAERS
808Oropharyngeal plaqueFAERS: 1US FAERS
809Orthostatic intoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
810OsteitisFAERS: 1US FAERS
811Otitis MediaFAERS: 1US FAERS
812OverweightFAERS: 1US FAERS
813Oxygen supplementationFAERS: 1US FAERS
814PCO2 decreasedFAERS: 1US FAERS
815PO2 decreasedFAERS: 1US FAERS
816Pain managementFAERS: 1US FAERS
817Palmar erythemaFAERS: 1US FAERS
818ParotitisFAERS: 1US FAERS
819Patent ductus arteriosusFAERS: 1US FAERS
820Pathogen resistanceFAERS: 1OFFSIDES
US FAERS
821Pelvic Inflammatory DiseaseFAERS: 1US FAERS
822Periorbital disorderFAERS: 1US FAERS
823PeritonitisFAERS: 1US FAERS
824PharyngitisFAERS: 1SIDER
US FAERS
825PhlebitisFAERS: 1US FAERS
826PhotophobiaFAERS: 1US FAERS
827Pilonidal CystFAERS: 1US FAERS
828Pneumococcal sepsisFAERS: 1US FAERS
829PneumoconiosisFAERS: 1US FAERS
830Post-Traumatic Stress DisorderFAERS: 1US FAERS
831Product administration errorFAERS: 1US FAERS
832Product dispensing errorFAERS: 1US FAERS
833Product distribution issueFAERS: 1US FAERS
834Product packaging issueFAERS: 1US FAERS
835Product size issueFAERS: 1US FAERS
836Product storage errorFAERS: 1US FAERS
837Product substitution issueFAERS: 1US FAERS
838PseudocystFAERS: 1US FAERS
839Pseudomonal sepsisFAERS: 1OFFSIDES
SIDER
US FAERS
840Pseudomonas test positiveFAERS: 1US FAERS
841Psychiatric symptomFAERS: 1US FAERS
842Pulmonary endarterectomyFAERS: 1US FAERS
843Pulmonary function test decreasedFAERS: 1US FAERS
844Pulmonary malformationFAERS: 1US FAERS
845Pulmonary vascular disorderFAERS: 1US FAERS
846PurulenceFAERS: 1US FAERS
847Purulent dischargeFAERS: 1OFFSIDES
US FAERS
848Rebound effectFAERS: 1US FAERS
849Rectal dischargeFAERS: 1US FAERS
850Reflux gastritisFAERS: 1US FAERS
851Renal painFAERS: 1US FAERS
852Respiratory DepressionFAERS: 1US FAERS
853Respiratory TherapyFAERS: 1US FAERS
854Retinal vascular occlusionFAERS: 1US FAERS
855Retinopathy of PrematurityFAERS: 1US FAERS
856RhinitisFAERS: 1SIDER
US FAERS
857Right Ventricular HypertrophyFAERS: 1US FAERS
858Right atrial pressure increasedFAERS: 1US FAERS
859Rotator cuff syndromeFAERS: 1US FAERS
860Salivary gland painFAERS: 1US FAERS
861SalpingectomyFAERS: 1US FAERS
862SarcomaFAERS: 1US FAERS
863SchizophreniaFAERS: 1US FAERS
864ScreamingFAERS: 1US FAERS
865Sedation complicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
866SeromaFAERS: 1US FAERS
867Serotonin SyndromeFAERS: 1US FAERS
868Shunt infectionFAERS: 1US FAERS
869Shunt malfunctionFAERS: 1US FAERS
870Sinus operationFAERS: 1US FAERS
871Sleep TalkingFAERS: 1US FAERS
872Small intestine carcinoma stage IVFAERS: 1US FAERS
873Spinal StenosisFAERS: 1US FAERS
874SplenectomyFAERS: 1US FAERS
875Sputum retentionFAERS: 1US FAERS
876Squamous cell carcinoma of lungFAERS: 1US FAERS
877Staphylococcus test positiveFAERS: 1US FAERS
878StaringFAERS: 1US FAERS
879Stenotrophomonas infectionFAERS: 1OFFSIDES
US FAERS
880Stress echocardiogram abnormalFAERS: 1US FAERS
881Superficial vein prominenceFAERS: 1US FAERS
882Superior Mesenteric Artery SyndromeFAERS: 1US FAERS
883Surgical vascular shuntFAERS: 1US FAERS
884Suspected product contaminationFAERS: 1US FAERS
885Syringe issueFAERS: 1US FAERS
886Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
887Temperature intoleranceFAERS: 1US FAERS
888Therapeutic product ineffectiveFAERS: 1US FAERS
889Therapeutic reaction time decreasedFAERS: 1US FAERS
890ThoracostomyFAERS: 1US FAERS
891Throat cancerFAERS: 1US FAERS
892ThromboembolectomyFAERS: 1US FAERS
893ThrombophlebitisFAERS: 1SIDER
US FAERS
894Thyroid hormones increasedFAERS: 1US FAERS
895Tongue bitingFAERS: 1US FAERS
896Tongue erythemaFAERS: 1US FAERS
897Tooth ErosionFAERS: 1US FAERS
898Tooth LossFAERS: 1US FAERS
899Tooth ResorptionFAERS: 1US FAERS
900Toxic Shock SyndromeFAERS: 1US FAERS
901Tracheal StenosisFAERS: 1US FAERS
902TracheobronchitisFAERS: 1US FAERS
903TracheomalaciaFAERS: 1US FAERS
904TrichorrhexisFAERS: 1US FAERS
905Umbilical herniaFAERS: 1US FAERS
906Unevaluable investigationFAERS: 1US FAERS
907Unintentional medical device removalFAERS: 1US FAERS
908Upper respiratory tract congestionFAERS: 1US FAERS
909Urethral dischargeFAERS: 1US FAERS
910Urine output increasedFAERS: 1US FAERS
911VIIth nerve paralysisFAERS: 1US FAERS
912Vaginal DischargeFAERS: 1US FAERS
913Vascular occlusionFAERS: 1US FAERS
914Venous occlusionFAERS: 1US FAERS
915Ventilation/perfusion scan abnormalFAERS: 1US FAERS
916Ventricle ruptureFAERS: 1US FAERS
917Ventricular DysfunctionFAERS: 1US FAERS
918Ventricular arrhythmiaFAERS: 1US FAERS
919Viral sinusitisFAERS: 1OFFSIDES
US FAERS
920Vital functions abnormalFAERS: 1US FAERS
921Vocal Cord ParalysisFAERS: 1US FAERS
922Vulvovaginal erythemaFAERS: 1US FAERS
923Vulvovaginal mycotic infectionFAERS: 1US FAERS
924Vulvovaginal swellingFAERS: 1US FAERS
925Waist circumference increasedFAERS: 1US FAERS
926West Nile viral infectionFAERS: 1US FAERS
927Wound ComplicationFAERS: 1US FAERS
928Wound abscessFAERS: 1US FAERS
929Wound infection bacterialFAERS: 1OFFSIDES
US FAERS
930Wound infection staphylococcalFAERS: 1OFFSIDES
US FAERS
931Wrong doseFAERS: 1US FAERS
932Wrong product administeredFAERS: 1US FAERS
933X-ray abnormalFAERS: 1US FAERS
934YawningFAERS: 1US FAERS
935colonoscopyFAERS: 1US FAERS
936furuncleFAERS: 1US FAERS
937muscle injuryFAERS: 1US FAERS
938Abdominal massOFFSIDES
939Acid fast bacilli infectionOFFSIDES
940AnorexiaSIDER
941Axillary vein thrombosisOFFSIDES
942Bacterial EndocarditisOFFSIDES
943Blood albumin decreasedOFFSIDES
944Body TemperatureOFFSIDES
945Catheter sepsisOFFSIDES
946Cramps of lower extremitiesSIDER
947Culture positiveOFFSIDES
948DiarrheaOFFSIDES
949EcchymosisSIDER
950HepatitisOFFSIDES
951Incorrect drug administration durationOFFSIDES
952IndurationSIDER
953Intra-abdominal fluid collectionCanada Vigilance: 1Canada Vigilance
954Mycobacterium fortuitum infectionOFFSIDES
955Pelvic discomfortCanada Vigilance: 1Canada Vigilance
956PericardiotomyOFFSIDES
957Pharyngolaryngeal PainSIDER
958Poor personal hygieneOFFSIDES
959Propionibacterium infectionOFFSIDES
960Protein total decreasedOFFSIDES
961Stenotrophomonas sepsisOFFSIDES
962Suprapubic painOFFSIDES
963TensionSIDER
964Venous stenosisOFFSIDES
965Venous thrombosis limbOFFSIDES
966Wheelchair userCanada Vigilance: 1Canada Vigilance
967White blood cell count abnormalOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.